Efficacy and Safety of Ziprasidone to Treat Depressive Symptoms in Patients With Schizophrenia

Conditions

• The Primary Evaluation is the Change From Baseline at End of Study for CDSS Total Scores.
• The Secondary Efficacy Evaluations Include: MADRS, PANSS Total Scores and Subscales and Responder Rate; CGI-S and CGI-I Scales.
• Safety Evaluations Include: Laboratory Test Abnormalities; BARS and SAS; Physical Examinations; Vital Signs; Electrocardiogram,Etc.
• Subjective Well-being Under Neuroleptics Short Form Will be Used in Our Study to Assess the Subjective Side-effects.

Sponsor

Wuhan University

Collaborators

• [object Object]
• [object Object]